Healthcare provider profile · identity verified

Michael James Geer, MD

Internal Medicine · BIRMINGHAM, AL · NPI 1669583498

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	670	218
Atorvastatin Calcium	Atorvastatin Calcium	485	162
Losartan Potassium	Losartan Potassium	334	119
Lisinopril	Lisinopril	332	116
Gabapentin	Gabapentin	310	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	254	46
Metoprolol Succinate	Metoprolol Succinate	242	72
Hydrochlorothiazide	Hydrochlorothiazide	213	76
Metformin Hcl	Metformin Hcl	212	78
Levothyroxine Sodium	Levothyroxine Sodium	211	69
Rosuvastatin Calcium	Rosuvastatin Calcium	206	83
Tramadol Hcl	Tramadol Hcl	196	60
Omeprazole	Omeprazole	194	67
Furosemide	Furosemide	175	58
Pantoprazole Sodium	Pantoprazole Sodium	173	60
Tamsulosin Hcl	Tamsulosin Hcl	153	55
Eliquis	Apixaban	137	34
Carvedilol	Carvedilol	136	51
Hydralazine Hcl	Hydralazine Hcl	126	43
Pravastatin Sodium	Pravastatin Sodium	121	46
Trazodone Hcl	Trazodone Hcl	121	36
Simvastatin	Simvastatin	120	37
Fluticasone Propionate	Fluticasone Propionate	116	41
Allopurinol	Allopurinol	102	35
Sertraline Hcl	Sertraline Hcl	99	40
Albuterol Sulfate Hfa	Albuterol Sulfate	92	35
Duloxetine Hcl	Duloxetine Hcl	92	30
Potassium Chloride	Potassium Chloride	92	30
Clonazepam	Clonazepam	88	17
Metoprolol Tartrate	Metoprolol Tartrate	88	34
Lovastatin	Lovastatin	86	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	23
Famotidine	Famotidine	83	22
Spironolactone	Spironolactone	78	28
Pregabalin	Pregabalin	75	22
Alendronate Sodium	Alendronate Sodium	72	27
Alprazolam	Alprazolam	72	14
Montelukast Sodium	Montelukast Sodium	68	20
Chlorthalidone	Chlorthalidone	66	26
Zolpidem Tartrate	Zolpidem Tartrate	66	11
Tizanidine Hcl	Tizanidine Hcl	65	22
Meloxicam	Meloxicam	60	25
Mirtazapine	Mirtazapine	55	17
Clopidogrel	Clopidogrel Bisulfate	52	20
Lorazepam	Lorazepam	51	16
Naproxen	Naproxen	51	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	16
Esomeprazole Magnesium	Esomeprazole Magnesium	49	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	17
Metformin Hcl Er	Metformin Hcl	48	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Diazepam	Diazepam	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	14
Farxiga	Dapagliflozin Propanediol	45	11
Ezetimibe	Ezetimibe	42	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Donepezil Hcl	Donepezil Hcl	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Ozempic	Semaglutide	38	suppressed
Ibuprofen	Ibuprofen	37	12
Baclofen	Baclofen	36	suppressed
Jardiance	Empagliflozin	36	11
Olmesartan Medoxomil	Olmesartan Medoxomil	35	11
Valsartan	Valsartan	35	13
Amitriptyline Hcl	Amitriptyline Hcl	33	12
Citalopram Hbr	Citalopram Hydrobromide	33	12
Finasteride	Finasteride	33	suppressed
Glimepiride	Glimepiride	33	11
Atenolol	Atenolol	32	12
Prednisone	Prednisone	31	13
Venlafaxine Hcl Er	Venlafaxine Hcl	31	11
Xarelto	Rivaroxaban	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Felodipine Er	Felodipine	27	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Colchicine	Colchicine	23	14
Diclofenac Sodium	Diclofenac Sodium	23	19
Fluconazole	Fluconazole	22	14
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Irbesartan	Irbesartan	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Synthroid	Levothyroxine Sodium	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Fosinopril Sodium	Fosinopril Sodium	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Humalog Kwikpen U-200	Insulin Lispro	16	suppressed
Azithromycin	Azithromycin	15	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lactulose	Lactulose	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Estradiol	Estradiol	13	suppressed
Glipizide	Glipizide	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Novolin R Flexpen	Insulin Regular, Human	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error